Schwab U.S. Broad Market ETF is in week 9 of a buy signal, up 9.38% from entry. All 3 targets of our most advanced model have been hit early, but the management roadmap runs through week 10 with the final reduction window.

Starbucks receives a sell signal in its first week, but the confirmation week closed higher: the model suggests exiting the position. Trading not recommended, stock 11.5% above the 200-week average, ranked 111th among 114 US sell signals.

Sanofi is in the 5th week of a sell signal, down -4.77%. The technical picture is mixed: the MACD histogram has reduced bearish pressure, but CMF has turned negative again and momentum continues to deteriorate. Our model flags elevated-risk conditions.

Safran is at week 2 of a buy signal on Euronext. The confirmation week closed bearish: the model flags an exit. The dynamic stop sits tight at -6% from entry; continuing the trade is at the trader's discretion.

Recursion Pharmaceuticals is in its 3rd week of a sell signal. The confirmation week closed bullish and the model suggests exiting the position: weakened signal, trading not recommended.

RTX Corporation is in week 11 of a sell signal. The decline is still active, but technical indicators point to a gradual fading of bearish pressure: rising buy volume, CMF back in positive territory, daily double bottom in the 171 area.